| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Here's Why Investors Should Stay Neutral on Lincoln National for Now | ||
| Do | Here's Why You Should Hold OPK Stock in Your Portfolio for Now | ||
| Do | Vornado Announces Meta's 10-Year Lease at 697 Fifth Avenue, Manhattan | ||
| Do | CAH Posts Strong Cash Flow, Eyes Next Steps in Capital Deployment | ||
| Do | Volvo Scraps EX30 U.S. Sales Amid Broader EV Strategy Reset | ||
| Do | 5 Dividend Growth Stocks to Buy Amid Rising Inflation Risk | ||
| Do | ICL Strengthens Specialty Fertilizers With New India Facility | ||
| Do | AMD vs. Broadcom: Which Semiconductor Stock is a Buy Right Now? | ||
| Do | PEG Set for Steady Growth on Clean Energy Investments & Strong Demand | ||
| Do | Can GEV Capitalize on the Exploding Power Demand From AI Data Centers? | ||
| Do | ILMN Stock Gains Following Expanded Collaboration With Labcorp | ||
| Do | Meta Platforms is Overvalued at 6.01X PS: Buy or Hold the Stock? | ||
| Do | Broadcom's AI Push Boosts Semiconductor Sales: More Upside Ahead? | ||
| Do | Berkshire Hathaway Stock Lost 3.6% YTD: Time to Buy the Dip? | ||
| Do | Centrus Energy Sees Modest 2025 Revenue Rise: Is a Rebound Ahead? | ||
| Do | AMGN Trading Above 50 & 200-Day SMA: How to Play the Stock? | ||
| Do | Will Kraft Heinz's NFL Deal Strengthen Its Growth Recovery Plan? | ||
| Do | J&J Expands New Drug Portfolio With Icotyde's FDA Approval | ||
| Do | Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why | ||
| Do | Oracle Pushes Up Capex Spending on AI: High Risk or High Reward? | ||
| Do | Micron Stock Slips Despite Blowout Earnings, Upbeat Guidance | ||
| Do | Texas Capital Soars 20.5% in a Year: Should You Buy the Stock Now? | ||
| Do | AT&T vs. Verizon: Which Telecom Stock Has Better Upside Now? | ||
| Do | SoFi's Loan Platform Business Emerges as a Capital-Light Growth Engine | ||
| Do | GNRC Boosts Industrial Power Portfolio With Advanced Diesel Generators |